Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Progenitor Cells and MSC Paracrine Factors for Newborn HIE
NCT02854579Unknown
- Start
- Jan 2013
- Primary completion
- Jul 2017
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of human mesenchymal stem cell paracrine factors in hypoxic-ischemic encephalopathy (HIE) (4 arms). Primary endpoints: Neonatal Behavioral Neurological Assessment at 28 days and Number of adverse events at 7 days. Status: unknown.
02
Drugs
human mesenchymal stem cell paracrine factors
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02854579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854579.